Netherlands· NL-92b623f04564
Implanon NXT, 68 mg implantaat voor subdermaal gebruik
A etonogestrel product containing etonogestrel, registered in Netherlands by N.V. Organon (Kloosterstraat 6). The same ATC class is registered in 14 of our 19 countries.
Checked against CBG-MEB (Netherlands) on
Informational only — not a medical device.
Where it is registered
Etonogestrel is registered in 14 of 19 countries.
Countries holding a registration under ATC G03AC08 (etonogestrel), each read from that country’s own register.
- This record: Netherlands, from CBG-MEB (Netherlands)
- 8 of them publish a price we can compare per daily dose
Etonogestrel · ATC G03AC08
14 / 19 countries
- Belgiumprice
- Canada
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of etonogestrel costs, country by country.
Normalised to the WHO defined daily dose (68 mcg), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Etonogestrel · price per daily dose (68 mcg)
USD · FX 28 Sept 2026
- ES Spain$0.17
The record
At a glance
CBG-MEB (Netherlands)- Active substance
- ETONOGESTREL
- Manufacturer
- N.V. Organon (Kloosterstraat 6)
- Country
- Netherlands (NL)
- ATC code
- G03AC08
- ATC class
- Etonogestrel
- Defined daily dose
- 68 mcg, s
- Reimbursed
- Not published by this register
- Source register
- CBG-MEB (Netherlands)
- Last checked
- September 29, 2026
Packs & prices · 1
- cbg_meb_id21168
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
181 interactions on record for etonogestrel.
Graded by severity as the source publishes them — 16 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Etonogestrel · interactions on record
181 records
- 16 severe
- 139 moderate
- 2 minor
Most severe, free to view
- Tranexamic acidB02AA02severe
- GriseofulvinD01AA08severe
- GriseofulvinD01BA01severe
- AcitretinD05BB02severe
24 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Etonogestrel in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumImplanon NXT 68 mgOrifarm
- SpainIMPLANON NXT 68 mg IMPLANTEOrganon Salud S.L.
- NorwayNexplanonN.V. Organon - Kloosterstraat
- PolandImplanon NXTOrganon Polska Sp. z o.o.
- SwedenNexplanon 68 mg ImplantatNV Organon
- United KingdomEtonogestrel 68mg implantNiche Pharma Ltd
- FinlandNexplanonN.V. Organon
- IrelandImplanon NXT, 68 mg implant for subdermal usePCO Manufacturing Ltd.
Authorised across Europe · EMA
The same active substance is authorised in 20 EEA countries. Names it is sold under:
- Austria · Implanon Nxt
- Belgium · Implanon Nxt
- Germany · Implanon Nxt
- Denmark · Nexplanon
- Estonia · Nexplanon
- Spain · Implanon Nxt
- Finland · Nexplanon
- France · Nexplanon
- United Kingdom (Northern Ireland) · Nexplanon
- Ireland · Implanon Nxt
- Iceland · Nexplanon
- Italy · Nexplanon
- Luxembourg · Implanon Nxt
- Malta · Implanon Nxt
- Norway · Nexplanon
- Poland · Implanon Nxt
- Portugal · Implanon Nxt
- Romania · Nexplanon
- Sweden · Nexplanon
- Slovakia · Implanon
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/bdc49f56-d5b6-4b8b-8358-da2e01764c37 GET /v1/drugs/bdc49f56-d5b6-4b8b-8358-da2e01764c37?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Implantaat",
"route": null,
"soort": "RVG",
"source": "cbg_meb",
"smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h21168_smpc.pdf",
"strength": null,
"atc_label": "Etonogestrel",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg21168",
"excipients": [
"BARIUMSULFAAT",
"COPOLYMEER VAN ETHYLEEN-VINYLACETAAT (15 pCt. vinylacetaat)",
"COPOLYMEER VAN ETHYLEEN-VINYLACETAAT (28 pCt. vinylacetaat)",
"MAGNESIUMSTEARAAT (E 470b)"
],
"substances": [
"ETONOGESTREL"
],
"leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h21168.pdf",
"authorised_at": "1998/08/25",
"procedure_number": "NL/H/0150/001",
"dispensing_status": "Uitsluitend recept",
"registration_number": "21168",
"additional_monitoring": "N"
}See everything about etonogestrel.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.